Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €2.26 EUR
Change Today -0.01 / -0.44%
Volume 1.4K
As of 8:09 AM 07/6/15 All times are local (Market data is delayed by at least 15 minutes).

generix - regr (GENX) Snapshot

Open
€2.29
Previous Close
€2.27
Day High
€2.29
Day Low
€2.25
52 Week High
05/4/15 - €2.45
52 Week Low
08/13/14 - €1.48
Market Cap
50.0M
Average Volume 10 Days
5.0K
EPS TTM
€0.03
Shares Outstanding
22.1M
EX-Date
05/3/00
P/E TM
72.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for GENERIX - REGR (GENX)

Related News

No related news articles were found.

generix - regr (GENX) Related Businessweek News

No Related Businessweek News Found

generix - regr (GENX) Details

Generix SA operates as a software vendor and software as a service provider in France and internationally. The company’s solutions include Generix Collaborative Supply Chain, a supply chain solution to manage logistics activities, including supply, delivery acceptance, storage, order picking, dispatching, transport, etc.; and Generix Collaborative Customer, a cross-channel platform for sales and marketing campaigns, which enable retailers to connect to the existing back office to carry out promotional, loyalty, and sales drives on front office applications. Its solutions also include Generix Collaborative Infrastructure, an integration and collaboration gateway that offers a B2B/A2A integration and collaboration solution in on premise or on demand mode. The company was founded in 1990 and is headquartered in Villeneuve d’Ascq, France.

Founded in 1990

generix - regr (GENX) Top Compensated Officers

Chairman of The Executive Board and Chief Exe...
Total Annual Compensation: €319.7K
Chief Financial Officer
Total Annual Compensation: €126.7K
Executive Vice President of Cloud & Applicati...
Total Annual Compensation: €181.2K
General Director and Member of Management Boa...
Total Annual Compensation: €222.2K
Director of Pole Quality Commitment & Informa...
Total Annual Compensation: €121.0K
Compensation as of Fiscal Year 2014.

generix - regr (GENX) Key Developments

Generix SA Reports Unaudited Group Earnings Results for the Year Ended March 31, 2015

Generix SA reported unaudited group earnings results for the year ended March 31, 2015. For the year, the company's revenues were EUR 53.7 million compared to EUR 49.4 million a year ago. This increase in revenue is primarily based on the success of the offers rolled out by the Group for the SaaS model which was confirmed over fiscal 2014/2015 with growth of 19% in the revenue generated by this business. Profit from current operations from continuing operations was EUR 4.2 million compared to EUR 3.9 million a year ago. Profit from operations from continuing operations was EUR 3.3 million compared to EUR 3.5 million a year ago. Profit before income taxes was EUR 3.0 million compared to EUR 3.1 million a year ago. Net result from continuing operations was EUR 2.0 million compared to EUR 4.3 million a year ago. Net result was EUR 0.8 million compared to EUR 3.7 million a year ago. Finally, the net income generated by the scope of the maintained activities amounts to EUR 2 million over fiscal 2014/2015 (which is 4% of revenue). EBITDA from continuing operations was EUR 4.9 million compared to EUR 4.8 million a year ago. Net cash by operating activities was EUR 2.2 million compared to EUR 4.0 million a year ago.

Generix Group Reports Unaudited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015

Generix Group reported unaudited earnings results for the fourth quarter and full year ended March 31, 2015. For the quarter, the company reported revenues from continued operations were EUR 14.271 million against EUR 12.392 million a year ago. With revenue of EUR 14.3 million, the group recorded for the past quarter an increase in revenue generated of 15% on the scope of the maintained activities primarily driven by: the dynamic rate of new SaaS signings observed since the beginning of the financial year 2013/2014, resulting in 36% growth in the revenue generated by this activity over the past quarter. This level of growth is linked to a 19% increase in the activity and to the opening of services for 17%; the new implementations generated by the SaaS signings, allowed Consulting and Services revenue to grow 12% compared with the same quarter of the previous financial year. The loyalty of the installed base (License-based) brought growth of 17% in license sales and growth of 2% in the revenue of the maintenance activity. For the year, the company reported revenues from continued operations were EUR 53.666 million against EUR 49.401 million a year ago. Fiscal 2014/2015 on the scope of the maintained activities allows the company to confirm the expected improvement in net cash flow at 31 March 2015 compared to 31 March 2014, and a level of profitability in terms of EBITDA close to that observed during fiscal 2013/2014.

Generix SA to Report Fiscal Year 2015 Results on Jun 01, 2015

Generix SA announced that they will report fiscal year 2015 results on Jun 01, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GENX:FP €2.26 EUR -0.01

GENX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GENX.
View Industry Companies
 

Industry Analysis

GENX

Industry Average

Valuation GENX Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GENERIX - REGR, please visit www.generixgroup.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.